gip/glp-1 drugs The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Personalized GLP-1/GIP+B12 - Kin Meds

After 14 months, there was a significant difference in motor and cognitive function measured by the Movement Disorders Society Unified PD Rating Scale (MDS-UPDRS) and Mattis dementia rating scale-2 (Mattis DRS-2), respectively

Some patients may need to wait for generic GLP-1 medications, which eventually will arrive on the scene

In addition, dapagliflozin attenuated the progression of diabetic cardiomyopathy by activating AMPK, mTOR and NOD-like receptor 3 (NLRP3) inflammasome in T2DM mice [105]

Medicare is funded by taxes, premiums that you pay for some parts of Medicare, investments, and other funds authorized by Congress

The statistical significance of the results from the meta-regression was consistent with the subgroup analyses

Image: Galina Zhigalova/Getty Images About the Author Maureen Salamon, Executive Editor, Harvard Women's Health Watch About the Reviewer Meghan Salamon, MS, RDN, LDN, CPT, Contributor Disclaimer: As a service to our readers, Harvard Health Publishing provides access to our library of archived content